Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
Shimon Slavin(Hadassah Medical Center), Reuven Or(Hadassah Academic College), Memet Aker(Hadassah Academic College), Ofira Ben‐Tal(Hadassah Academic College), Y. Kapelushnik(Hadassah Academic College), Arnon Nagler(Sheba Medical Center), E Naparstek(Hadassah Academic College), Mark Kirschbaum(Cyclacel Pharmaceuticals (United States)), Aliza Ackerstein(Hadassah Academic College), Chaim Brautbar(Hadassah Academic College), Avraham Amar(Hadassah Academic College), Simcha Samuel(Hadassah Academic College), A Eldor(Hadassah Academic College), Gàbor Varadi(Hadassah Academic College), Gabriel Cividalli(Hadassah Academic College)
Cited by 1,939
Related Papers
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859